Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease-Reference-Cited by-同舟云学术

Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease

Published:2021-03-16 Issue:4 Volume:73 Page:1275-1289
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Semmler Georg¹²^ORCID,Binter Teresa¹^ORCID,Kozbial Karin¹,Schwabl Philipp¹²^ORCID,Hametner‐Schreil Stefanie³,Zanetto Alberto⁴,Gavasso Sabrina⁵,Chromy David¹²^ORCID,Bauer David J.M.¹²^ORCID,Simbrunner Benedikt¹²^ORCID,Scheiner Bernhard¹²^ORCID,Bucsics Theresa¹²^ORCID,Stättermayer Albert F.¹²,Pinter Matthias¹²^ORCID,Steindl‐Munda Petra¹^ORCID,Schöfl Rainer³,Russo Francesco Paolo⁴^ORCID,Simioni Paolo⁵^ORCID,Trauner Michael¹^ORCID,Ferenci Peter¹^ORCID,Reiberger Thomas¹²^ORCID,Mandorfer Mattias¹²^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology Department of Internal Medicine III Medical University of Vienna Vienna Austria

2. Vienna Hepatic Hemodynamic LaboratoryMedical University of Vienna Vienna Austria

3. Internal Medicine IV Ordensklinikum Linz Barmherzige Schwestern Linz Austria

4. Gastroenterology and Multivisceral Transplant Unit Department of Surgery, Oncology, and Gastroenterology Padua University Hospital Padua Italy

5. General Internal Medicine and Thrombotic and Hemorrhagic Diseases Unit Department of Medicine Padua University Hospital Padua Italy

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31462

Reference37 articles.

1. Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses

2. Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

3. Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease

4. Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis

5. Persistence of Clinically Significant Portal Hypertension After Eradication of Hepatitis C Virus in Patients With Advanced Cirrhosis

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The survival prediction analysis and preliminary study of the biological function of YEATS2 in hepatocellular carcinoma;2024-08-28

2. Reticulated platelets are increased and hyper-activated in patients with cirrhosis, especially those with poor outcome;Digestive and Liver Disease;2024-08

3. Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure;Hepatology;2024-07-08

4. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure;Journal of Hepatology;2024-07

5. Novel approaches in the medical management of compensated cirrhosis;Expert Review of Gastroenterology & Hepatology;2024-05-28